Zinger Key Points
- Shares of Edwards Lifesciences gain by over 8% on Tuesday, breaking above their December high.
- The company is scheduled to report its fourth-quarter financial results in less than a week, on Feb. 6.
- Feel unsure about the market’s next move? Copy trade alerts from Matt Maley—a Wall Street veteran who consistently finds profits in volatile markets. Claim your 7-day free trial now.
Edwards Lifesciences Corporation EW shares traded higher on Wednesday. The stock surged despite any company-specific news.
What To Know: Edwards Lifesciences stock rose over 8% on Wednesday, although there were no major catalysts behind the move. The stock experienced above-average volume of 9.36 million shares, compared to its average volume of 4.18 million shares.
Previously, shares had rallied from the end of October to mid-December, at which point the stock trended lower into the end of January.
Over the past week however, shares have pushed higher, soaring above the December high.
Wednesday's move comes less than a week before the company is set to post its fourth-quarter financial results, scheduled for Feb. 6. Edwards Lifesciences is estimated to report earnings of 64 cents per share and revenue of $1.49 billion.
Related Link: Inogen Gets A Shout-Out From Citron Research On X: Here's What's Happening
EW Price Action: Shares of Edwards Lifesciences were up 6.16% at $78.45 at the close of the market, according to Benzinga Pro.
Image by Myriams-Fotos from Pixabay
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
